Company registration number 04325278 (England and Wales)
MEDICAL AIR TECHNOLOGY LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 JUNE 2025
PAGES FOR FILING WITH REGISTRAR
MEDICAL AIR TECHNOLOGY LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 7
MEDICAL AIR TECHNOLOGY LIMITED
BALANCE SHEET
- 1 -
30 June 2025
31 December 2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
6,285
8,670
Current assets
Debtors
5
2,254,961
1,816,569
Cash at bank and in hand
2,957
157,716
2,257,918
1,974,285
Creditors: amounts falling due within one year
6
(3,209,889)
(3,222,618)
Net current liabilities
(951,971)
(1,248,333)
Total assets less current liabilities
(945,686)
(1,239,663)
Creditors: amounts falling due after more than one year
7
(91,097)
(191,259)
Net liabilities
(1,036,783)
(1,430,922)
Capital and reserves
Called up share capital
73
73
Share premium account
4,283
4,283
Capital redemption reserve
30
30
Profit and loss reserves
(1,041,169)
(1,435,308)
Total equity
(1,036,783)
(1,430,922)
MEDICAL AIR TECHNOLOGY LIMITED
BALANCE SHEET (CONTINUED)
- 2 -
For the financial Period ended 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the Period in question in accordance with section 476.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
The financial statements were approved by the board of directors and authorised for issue on 25 September 2025 and are signed on its behalf by:
Mr B J J McCurdy
Director
Company registration number 04325278 (England and Wales)
MEDICAL AIR TECHNOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 JUNE 2025
- 3 -
1
Accounting policies
Company information
Medical Air Technology Limited is a private company limited by shares incorporated in England and Wales. The registered office is Unit 2, Mercury Way, Trafford Park, Manchester, Greater Manchester, England, M41 7LY.
1.1
Reporting period
[ FRS 102 3.10 An entity shall present a complete set of financial statements (including comparative information as set out in paragraph 3.14) at least annually. When the end of an entity’s reporting period changes and the annual financial statements are presented for a period longer or shorter than one year, the entity shall disclose the following: (a) that fact; (b) the reason for using a longer or shorter period; and (c) the fact that comparative amounts presented in the financial statements (including the related notes) are not entirely comparable. ]
1.2
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
Going concern
The accounts are prepared on a going concern basis
During the year ended 31 December 2024 the Company. secured a project to provide an Operating Theatre suite for an NHS trust in the north of England. This project was working for a Modular Building contractor. During the project it became clear that the contractor was experiencing financial difficulties but gave assurances that all payments due would be made. In good faith the Company completed the project and provided a first-class facility to the NHS Trust. Unfortunately, the contractor reneged on their commitment to settle amounts due to the Company, and subsequently entered into an insolvency arrangement. This has led to a significant bad debt crystalising in the 2024 financial statements. The Company has refinanced to ensure that all sub-contractors and suppliers were paid in full. The funding has also enabled the Company to continue trading profitably and secure new orders.
The directors remain confident that for the foreseeable future, the company can continue to trade, and to meet its financial obligations as and when the fall due, No provision has therefore been made for the difference between asset values appearing in the balance sheet, and their realisable values should the company be wound up, nor for any costs of insolvency.
1.3
Turnover
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.
MEDICAL AIR TECHNOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 JUNE 2025
1
Accounting policies
(Continued)
- 4 -
Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recoverable.
1.4
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Leasehold improvements
Over the term of the lease
Plant and equipment
25% on cost
Fixtures and fittings
33% on cost
Computers
33% on cost
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
1.5
Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
1.6
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.7
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.8
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
MEDICAL AIR TECHNOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 JUNE 2025
1
Accounting policies
(Continued)
- 5 -
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
1.9
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.10
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.11
Leases
As lessee
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.
1.12
Expenditure on research and development is written off in the year in which it is incurred.
2
Judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
3
Employees
The average monthly number of persons (including directors) employed by the company during the Period was:
2025
2024
Number
Number
Total
14
19
MEDICAL AIR TECHNOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 JUNE 2025
- 6 -
4
Tangible fixed assets
Leasehold improvements
Plant and equipment
Fixtures and fittings
Computers
Total
£
£
£
£
£
Cost
At 1 January 2025
14,942
308
56,529
42,989
114,768
Additions
1,480
1,480
At 30 June 2025
14,942
308
56,529
44,469
116,248
Depreciation and impairment
At 1 January 2025
14,942
308
55,582
35,266
106,098
Depreciation charged in the Period
315
3,550
3,865
At 30 June 2025
14,942
308
55,897
38,816
109,963
Carrying amount
At 30 June 2025
632
5,653
6,285
At 31 December 2024
947
7,723
8,670
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
1,431,870
1,039,318
Gross amounts owed by contract customers
504,139
504,760
Amounts owed by group undertakings
115,000
Other debtors
25,964
11,985
Prepayments and accrued income
126,394
55,707
2,203,367
1,611,770
2025
2024
Amounts falling due after more than one year:
£
£
Deferred tax asset (note )
51,594
204,799
Total debtors
2,254,961
1,816,569
MEDICAL AIR TECHNOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 JUNE 2025
- 7 -
6
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
1,800,932
1,782,783
Amounts owed to group undertakings
3,840
606,227
Taxation and social security
70,711
78,017
Other creditors
1,334,406
755,591
3,209,889
3,222,618
7
Creditors: amounts falling due after more than one year
2025
2024
£
£
Other creditors
91,097
191,259
8
Loans and overdrafts
2025
2024
£
£
Other loans
275,481
349,340
Payable within one year
184,384
158,081
Payable after one year
91,097
191,259
Included in "Other creditors" are other loans as shown above, which are secured by means of directors' personal guarantees.
9
Operating lease commitments
As lessee
At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:
2025
2024
£
£
Total commitments
408,504
515,532
10
Parent company
The company's ultimate parent company and ultimate controlling party is Medical Air Technology (Holdings) Limited, whose registered office address is Unit 2 Mercury Way, Trafford Park, Manchester, Greater Manchester, M41 7LY.